Compared to the NSCLC patients, the frequency of IFN-γ, TNF-α, and/or double-positive CD4+ Tcm cells in the blood was higher in the healthy donors (p < 0.01) (Fig. 3b). This evidence concerns the gene CD4 and non-small cell lung carcinoma.